Johnson and Johnson (France)

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

These companies are organized into three global business units:

Central Nervous System and Internal Medicine

This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.

B.I.O. (Biotechnology, Immunology & Oncology)

This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.

Virology

This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.

Contact Details: rue camille desmoulins issy les moulineaux cedex 9 F-92787 France Tel: 33-155004174 Fax: Email: WWW: www.jnj.com

BioNews Results for Johnson and Johnson (France):
Sunday start for Amgen Tour considered a boon for tourism	San Francisco Business Times:  Oct 30 2009 9:20PM Matching: johnson france
Analysis of the current and future anticonvulsant drug class market	News-Medical.Net:  Oct 29 2009 9:33AM Matching: johnson france
Winning placement on Managed Care formularies, the first step for product's increased market share	News-Medical.Net:  Oct 29 2009 10:20AM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions	Forbes.com:  Oct 28 2009 4:29PM Matching: johnson france
Research and Markets: Commercial Insight: Anticonvulsants - Non-Epilepsy Label Expansions Provide Blockbuster	Business Wire:  Oct 28 2009 4:10PM Matching: johnson france
Promote your company here: BioNewsCast - Press Release Distribution	→View more Johnson and Johnson (France) news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 5015 times since April 2007, the link to the organisation's website has been followed 188 times

Recent Search Terms used to find this page: johnson and johnson france | johnson johnson france | johnson johnson france | search about johnson fr | johnson johnson france | johnson johnson france | johnson johnson frankreich | Johnson Johnson .fr | jnj france | johnson and johnson france market | .

Search for more companies in issy les moulineaux cedex 9

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Johnson and Johnson (France)